A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer

Judith K. Wolf, Diane C. Bodurka, Jacalyn B. Gano, Michael Deavers, Lois Ramondetta, Pedro T. Ramirez, Charles Levenback, David M. Gershenson

Research output: Contribution to journalArticle

64 Scopus citations

Fingerprint Dive into the research topics of 'A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences